Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
GE Vernova enters its October 22 earnings date with the stock at $1,029, up 7% on the week and nearly 10% over the past month, and with bears doing little to stand in the way.
The lending market tells a story of almost no short-selling pressure. Availability has surged to 4,532%, more than double where it was just a fortnight ago, meaning there are roughly 45 shares available to borrow for every one already shorted. That is the highest availability reading in at least a year, and it reflects a lending pool that is growing faster than short interest is being rebuilt. SI has edged down nearly 3% over the week to just under 3% of the free float, well inside the zone where it becomes a primary story. Cost to borrow is a negligible 0.38%, down 18% over the past month, confirming that there is no friction in the lending market and no meaningful queue of sellers waiting to pile in. The ORTEX short score, at 35.3, has drifted lower all week, consistent with a market that is not building a short thesis here.
Options positioning is mildly more defensive than usual, but not dramatically so. The put/call ratio has eased to 1.39 this week, slightly below its 20-day average of 1.41 and running about 1.3 standard deviations below the mean. For context, GEV's PCR has been structurally elevated all year, with the 52-week high at 1.50 and the low at 0.96, so the current level simply reflects a stock where hedging is always relatively popular. The week's drift lower in the PCR is consistent with the price rally: investors are trimming protection into strength rather than adding it.
The Street remains firmly constructive, with the mean analyst price target at $1,230, roughly 20% above the current price. After Q2 results in late July, a broad cluster of firms raised targets: Morgan Stanley went to $1,350, JPMorgan to $1,330, Guggenheim to $1,450, and Oppenheimer to $1,338, all maintaining positive ratings. The most recent note of interest came in mid-September, when GLJ Research initiated with a Sell and a $470 target, a figure so far below the current price that it flags as an outlier against a consensus that is overwhelmingly constructive. Bernstein reiterated Outperform at $1,298 the following day, underscoring the divide. The bull case rests on record orders: Q2 total orders hit $24.2bn, an 88% organic jump, with a 2.18x book-to-bill and raised full-year guidance of $45.5bn to $46.5bn in revenue. The bear case points to a slight Q2 EBITDA miss, a Q3 guide at or slightly below consensus, and deep losses in Wind, where revenue fell 10% year-on-year and EBITDA margin ran at negative 13.6%. At 45x trailing earnings and 15x book, the valuation already prices in a lot of the good news: the EV/EBITDA multiple has expanded 30 basis points over the past 30 days to 30.4x, and the price-to-book ratio has climbed nearly a full turn over the same period.
Institutional ownership is concentrated and largely passive. BlackRock holds 8.2% of shares, having added just over a million shares in the most recent quarter. Capital Research added roughly 506,000 shares to reach a 2.5% stake. There is no active 13D filer on the register. The most recent insider activity of note was a discretionary sale by the CEO of Wind in early June at $948, capturing gains well below where the stock trades today, while the Chief Accounting Officer sold 2,333 shares at $1,059 in May. Neither trade was under a 10b5-1 plan. Net insider activity was negative over the 90 days to June, though the data is now over four months stale and should be read as context rather than current signal.
With the Q3 print 15 days away, the question is less about positioning, which is loose on all measures, and more about whether the Power order momentum can offset another difficult quarter in Wind and whether Q3 EBITDA lands above or below a consensus that was already described as "in line to slightly below" by management's own Q3 guide. Peer ETN gained 2.7% on the week and NVT added 7.5%, so GEV's 7% move is broadly consistent with a sector that had a strong week rather than a company-specific re-rating. The October 22 print will determine whether the expanded backlog translates into the kind of margin delivery the Street's targets require.
See the live data behind this article on ORTEX.
Open GEV on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
